Identification of the molecular site of ivabradine binding to HCN4 channels.

Ivabradine is a specific heart rate-reducing agent approved as a treatment of chronic stable angina. Its mode of action involves a selective and specific block of HCN channels, the molecular components of sinoatrial "funny" (f)-channels. Different studies suggest that the binding site of i...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Annalisa Bucchi, Mirko Baruscotti, Marco Nardini, Andrea Barbuti, Stefano Micheloni, Martino Bolognesi, Dario DiFrancesco
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/6779caee5bf1410c9d6a58ff18238140
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6779caee5bf1410c9d6a58ff18238140
record_format dspace
spelling oai:doaj.org-article:6779caee5bf1410c9d6a58ff182381402021-11-18T08:02:40ZIdentification of the molecular site of ivabradine binding to HCN4 channels.1932-620310.1371/journal.pone.0053132https://doaj.org/article/6779caee5bf1410c9d6a58ff182381402013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23308150/?tool=EBIhttps://doaj.org/toc/1932-6203Ivabradine is a specific heart rate-reducing agent approved as a treatment of chronic stable angina. Its mode of action involves a selective and specific block of HCN channels, the molecular components of sinoatrial "funny" (f)-channels. Different studies suggest that the binding site of ivabradine is located in the inner vestibule of HCN channels, but the molecular details of ivabradine binding are unknown. We thus sought to investigate by mutagenesis and in silico analysis which residues of the HCN4 channel, the HCN isoform expressed in the sinoatrial node, are involved in the binding of ivabradine. Using homology modeling, we verified the presence of an inner cavity below the channel pore and identified residues lining the cavity; these residues were replaced with alanine (or valine) either alone or in combination, and WT and mutant channels were expressed in HEK293 cells. Comparison of the block efficiency of mutant vs WT channels, measured by patch-clamp, revealed that residues Y506, F509 and I510 are involved in ivabradine binding. For each mutant channel, docking simulations correctly explain the reduced block efficiency in terms of proportionally reduced affinity for ivabradine binding. In summary our study shows that ivabradine occupies a cavity below the channel pore, and identifies specific residues facing this cavity that interact and stabilize the ivabradine molecule. This study provides an interpretation of known properties of f/HCN4 channel block by ivabradine such as the "open channel block", the current-dependence of block and the property of "trapping" of drug molecules in the closed configuration.Annalisa BucchiMirko BaruscottiMarco NardiniAndrea BarbutiStefano MicheloniMartino BolognesiDario DiFrancescoPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 1, p e53132 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Annalisa Bucchi
Mirko Baruscotti
Marco Nardini
Andrea Barbuti
Stefano Micheloni
Martino Bolognesi
Dario DiFrancesco
Identification of the molecular site of ivabradine binding to HCN4 channels.
description Ivabradine is a specific heart rate-reducing agent approved as a treatment of chronic stable angina. Its mode of action involves a selective and specific block of HCN channels, the molecular components of sinoatrial "funny" (f)-channels. Different studies suggest that the binding site of ivabradine is located in the inner vestibule of HCN channels, but the molecular details of ivabradine binding are unknown. We thus sought to investigate by mutagenesis and in silico analysis which residues of the HCN4 channel, the HCN isoform expressed in the sinoatrial node, are involved in the binding of ivabradine. Using homology modeling, we verified the presence of an inner cavity below the channel pore and identified residues lining the cavity; these residues were replaced with alanine (or valine) either alone or in combination, and WT and mutant channels were expressed in HEK293 cells. Comparison of the block efficiency of mutant vs WT channels, measured by patch-clamp, revealed that residues Y506, F509 and I510 are involved in ivabradine binding. For each mutant channel, docking simulations correctly explain the reduced block efficiency in terms of proportionally reduced affinity for ivabradine binding. In summary our study shows that ivabradine occupies a cavity below the channel pore, and identifies specific residues facing this cavity that interact and stabilize the ivabradine molecule. This study provides an interpretation of known properties of f/HCN4 channel block by ivabradine such as the "open channel block", the current-dependence of block and the property of "trapping" of drug molecules in the closed configuration.
format article
author Annalisa Bucchi
Mirko Baruscotti
Marco Nardini
Andrea Barbuti
Stefano Micheloni
Martino Bolognesi
Dario DiFrancesco
author_facet Annalisa Bucchi
Mirko Baruscotti
Marco Nardini
Andrea Barbuti
Stefano Micheloni
Martino Bolognesi
Dario DiFrancesco
author_sort Annalisa Bucchi
title Identification of the molecular site of ivabradine binding to HCN4 channels.
title_short Identification of the molecular site of ivabradine binding to HCN4 channels.
title_full Identification of the molecular site of ivabradine binding to HCN4 channels.
title_fullStr Identification of the molecular site of ivabradine binding to HCN4 channels.
title_full_unstemmed Identification of the molecular site of ivabradine binding to HCN4 channels.
title_sort identification of the molecular site of ivabradine binding to hcn4 channels.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/6779caee5bf1410c9d6a58ff18238140
work_keys_str_mv AT annalisabucchi identificationofthemolecularsiteofivabradinebindingtohcn4channels
AT mirkobaruscotti identificationofthemolecularsiteofivabradinebindingtohcn4channels
AT marconardini identificationofthemolecularsiteofivabradinebindingtohcn4channels
AT andreabarbuti identificationofthemolecularsiteofivabradinebindingtohcn4channels
AT stefanomicheloni identificationofthemolecularsiteofivabradinebindingtohcn4channels
AT martinobolognesi identificationofthemolecularsiteofivabradinebindingtohcn4channels
AT dariodifrancesco identificationofthemolecularsiteofivabradinebindingtohcn4channels
_version_ 1718422607413379072